IBDEI0CT ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17122,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17122,1,4,0)
 ;;=4^404.12
 ;;^UTILITY(U,$J,358.3,17122,1,5,0)
 ;;=5^Htn With Heart Involvement & Renal Failure
 ;;^UTILITY(U,$J,358.3,17122,2)
 ;;=^269620
 ;;^UTILITY(U,$J,358.3,17123,0)
 ;;=404.13^^110^980^46
 ;;^UTILITY(U,$J,358.3,17123,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17123,1,4,0)
 ;;=4^404.13
 ;;^UTILITY(U,$J,358.3,17123,1,5,0)
 ;;=5^Htn With CHF & Renal Failure
 ;;^UTILITY(U,$J,358.3,17123,2)
 ;;=^269621
 ;;^UTILITY(U,$J,358.3,17124,0)
 ;;=401.9^^110^980^53
 ;;^UTILITY(U,$J,358.3,17124,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17124,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,17124,1,5,0)
 ;;=5^Hypertension, Essential
 ;;^UTILITY(U,$J,358.3,17124,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,17125,0)
 ;;=272.0^^110^980^51
 ;;^UTILITY(U,$J,358.3,17125,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17125,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,17125,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,17125,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,17126,0)
 ;;=272.1^^110^980^54
 ;;^UTILITY(U,$J,358.3,17126,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17126,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,17126,1,5,0)
 ;;=5^Hypertriglyceridemia
 ;;^UTILITY(U,$J,358.3,17126,2)
 ;;=Hypertriglyceridemia^101303
 ;;^UTILITY(U,$J,358.3,17127,0)
 ;;=272.2^^110^980^59
 ;;^UTILITY(U,$J,358.3,17127,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17127,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,17127,1,5,0)
 ;;=5^Mixed Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,17127,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,17128,0)
 ;;=454.0^^110^980^83
 ;;^UTILITY(U,$J,358.3,17128,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17128,1,4,0)
 ;;=4^454.0
 ;;^UTILITY(U,$J,358.3,17128,1,5,0)
 ;;=5^Vericose Veins
 ;;^UTILITY(U,$J,358.3,17128,2)
 ;;=Vericose Veins^125410
 ;;^UTILITY(U,$J,358.3,17129,0)
 ;;=454.2^^110^980^84
 ;;^UTILITY(U,$J,358.3,17129,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17129,1,4,0)
 ;;=4^454.2
 ;;^UTILITY(U,$J,358.3,17129,1,5,0)
 ;;=5^Vericose Veins W/Ulcer&Inflammation
 ;;^UTILITY(U,$J,358.3,17129,2)
 ;;=^269821
 ;;^UTILITY(U,$J,358.3,17130,0)
 ;;=396.0^^110^980^8
 ;;^UTILITY(U,$J,358.3,17130,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17130,1,4,0)
 ;;=4^396.0
 ;;^UTILITY(U,$J,358.3,17130,1,5,0)
 ;;=5^Aortic And Mitral Valve Stenosis
 ;;^UTILITY(U,$J,358.3,17130,2)
 ;;=Aortic and Mitral Stenosis^269580
 ;;^UTILITY(U,$J,358.3,17131,0)
 ;;=414.02^^110^980^18
 ;;^UTILITY(U,$J,358.3,17131,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17131,1,4,0)
 ;;=4^414.02
 ;;^UTILITY(U,$J,358.3,17131,1,5,0)
 ;;=5^CAD, Occlusion Of Venous Graft
 ;;^UTILITY(U,$J,358.3,17131,2)
 ;;=CAD, Occlusion of Venous Graft^303282
 ;;^UTILITY(U,$J,358.3,17132,0)
 ;;=459.10^^110^980^70
 ;;^UTILITY(U,$J,358.3,17132,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17132,1,4,0)
 ;;=4^459.10
 ;;^UTILITY(U,$J,358.3,17132,1,5,0)
 ;;=5^Post Phlebotic Syndrome
 ;;^UTILITY(U,$J,358.3,17132,2)
 ;;=Post Phlebotic Syndrome^328597
 ;;^UTILITY(U,$J,358.3,17133,0)
 ;;=428.20^^110^980^45
 ;;^UTILITY(U,$J,358.3,17133,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17133,1,4,0)
 ;;=4^428.20
 ;;^UTILITY(U,$J,358.3,17133,1,5,0)
 ;;=5^Heart Failure, Systolic, Unspec
 ;;^UTILITY(U,$J,358.3,17133,2)
 ;;=Heart Failure, Systolic^328594
 ;;^UTILITY(U,$J,358.3,17134,0)
 ;;=428.21^^110^980^35
 ;;^UTILITY(U,$J,358.3,17134,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17134,1,4,0)
 ;;=4^428.21
 ;;^UTILITY(U,$J,358.3,17134,1,5,0)
 ;;=5^Heart Failure, Acute Systolic
 ;;^UTILITY(U,$J,358.3,17134,2)
 ;;=Heart Failure, Acute Systolic^328494
 ;;^UTILITY(U,$J,358.3,17135,0)
 ;;=428.22^^110^980^37
 ;;^UTILITY(U,$J,358.3,17135,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17135,1,4,0)
 ;;=4^428.22
 ;;^UTILITY(U,$J,358.3,17135,1,5,0)
 ;;=5^Heart Failure, Chronic Systolic
 ;;^UTILITY(U,$J,358.3,17135,2)
 ;;=Heart Failure, Chronic Systolic^328495
 ;;^UTILITY(U,$J,358.3,17136,0)
 ;;=428.23^^110^980^44
 ;;^UTILITY(U,$J,358.3,17136,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17136,1,4,0)
 ;;=4^428.23
 ;;^UTILITY(U,$J,358.3,17136,1,5,0)
 ;;=5^Heart Failure, Systolic, Acute On Chronic
 ;;^UTILITY(U,$J,358.3,17136,2)
 ;;=Heart Failure, Systolic, Acute on Chronic^328496
 ;;^UTILITY(U,$J,358.3,17137,0)
 ;;=428.30^^110^980^38
 ;;^UTILITY(U,$J,358.3,17137,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17137,1,4,0)
 ;;=4^428.30
 ;;^UTILITY(U,$J,358.3,17137,1,5,0)
 ;;=5^Heart Failure, Diastolic
 ;;^UTILITY(U,$J,358.3,17137,2)
 ;;=Heart Failure, Diastolic^328595
 ;;^UTILITY(U,$J,358.3,17138,0)
 ;;=428.31^^110^980^34
 ;;^UTILITY(U,$J,358.3,17138,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17138,1,4,0)
 ;;=4^428.31
 ;;^UTILITY(U,$J,358.3,17138,1,5,0)
 ;;=5^Heart Failure, Acute Diastolic
 ;;^UTILITY(U,$J,358.3,17138,2)
 ;;=Heart Failure, Acute Diastolic^328497
 ;;^UTILITY(U,$J,358.3,17139,0)
 ;;=428.32^^110^980^36
 ;;^UTILITY(U,$J,358.3,17139,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17139,1,4,0)
 ;;=4^428.32
 ;;^UTILITY(U,$J,358.3,17139,1,5,0)
 ;;=5^Heart Failure, Chronic Diastolic
 ;;^UTILITY(U,$J,358.3,17139,2)
 ;;=Heart Failure, Chronic Diastolic^328498
 ;;^UTILITY(U,$J,358.3,17140,0)
 ;;=428.33^^110^980^40
 ;;^UTILITY(U,$J,358.3,17140,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17140,1,4,0)
 ;;=4^428.33
 ;;^UTILITY(U,$J,358.3,17140,1,5,0)
 ;;=5^Heart Failure, Diastolic, Acute On Chronic
 ;;^UTILITY(U,$J,358.3,17140,2)
 ;;=Heart Failure, Diastolic, Acute on Chronic^328499
 ;;^UTILITY(U,$J,358.3,17141,0)
 ;;=428.40^^110^980^39
 ;;^UTILITY(U,$J,358.3,17141,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17141,1,4,0)
 ;;=4^428.40
 ;;^UTILITY(U,$J,358.3,17141,1,5,0)
 ;;=5^Heart Failure, Diastolic& Systolic
 ;;^UTILITY(U,$J,358.3,17141,2)
 ;;=Heart Failure, Systolic and Diastolic^328596
 ;;^UTILITY(U,$J,358.3,17142,0)
 ;;=428.41^^110^980^41
 ;;^UTILITY(U,$J,358.3,17142,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17142,1,4,0)
 ;;=4^428.41
 ;;^UTILITY(U,$J,358.3,17142,1,5,0)
 ;;=5^Heart Failure, Systolic & Diastolic, Acute
 ;;^UTILITY(U,$J,358.3,17142,2)
 ;;=Heart Failure, Systolic & Diastolic, Acute^328500
 ;;^UTILITY(U,$J,358.3,17143,0)
 ;;=428.42^^110^980^43
 ;;^UTILITY(U,$J,358.3,17143,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17143,1,4,0)
 ;;=4^428.42
 ;;^UTILITY(U,$J,358.3,17143,1,5,0)
 ;;=5^Heart Failure, Systolic & Diastolic, Chronic
 ;;^UTILITY(U,$J,358.3,17143,2)
 ;;= Heart Failure, Systolic & Diastolic, Chronic^328501
 ;;^UTILITY(U,$J,358.3,17144,0)
 ;;=428.43^^110^980^42
 ;;^UTILITY(U,$J,358.3,17144,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17144,1,4,0)
 ;;=4^428.43
 ;;^UTILITY(U,$J,358.3,17144,1,5,0)
 ;;=5^Heart Failure, Systolic & Diastolic, Acute On Chronic
 ;;^UTILITY(U,$J,358.3,17144,2)
 ;;= Heart Failure, Systolic & Diastolic, Acute on Chronic^328502
 ;;^UTILITY(U,$J,358.3,17145,0)
 ;;=396.3^^110^980^7
 ;;^UTILITY(U,$J,358.3,17145,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17145,1,4,0)
 ;;=4^396.3
 ;;^UTILITY(U,$J,358.3,17145,1,5,0)
 ;;=5^Aortic And Mitral Insufficiency
 ;;^UTILITY(U,$J,358.3,17145,2)
 ;;=Aortic and Mitral Insufficiency^269583
 ;;^UTILITY(U,$J,358.3,17146,0)
 ;;=414.3^^110^980^17
 ;;^UTILITY(U,$J,358.3,17146,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17146,1,4,0)
 ;;=4^414.3
 ;;^UTILITY(U,$J,358.3,17146,1,5,0)
 ;;=5^CAD d/t Lipid Rich Plaque
 ;;^UTILITY(U,$J,358.3,17146,2)
 ;;=^336601
 ;;^UTILITY(U,$J,358.3,17147,0)
 ;;=453.9^^110^980^82
 ;;^UTILITY(U,$J,358.3,17147,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17147,1,4,0)
 ;;=4^453.9
 ;;^UTILITY(U,$J,358.3,17147,1,5,0)
 ;;=5^Venous Thrombosis NOS
 ;;^UTILITY(U,$J,358.3,17147,2)
 ;;=^39455
 ;;^UTILITY(U,$J,358.3,17148,0)
 ;;=453.89^^110^980^1
 ;;^UTILITY(U,$J,358.3,17148,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17148,1,4,0)
 ;;=4^453.89
 ;;^UTILITY(U,$J,358.3,17148,1,5,0)
 ;;=5^AC Venous Embolism NEC
 ;;^UTILITY(U,$J,358.3,17148,2)
 ;;=^338259
 ;;^UTILITY(U,$J,358.3,17149,0)
 ;;=453.79^^110^980^27
 ;;^UTILITY(U,$J,358.3,17149,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17149,1,4,0)
 ;;=4^453.79
 ;;^UTILITY(U,$J,358.3,17149,1,5,0)
 ;;=5^Chr Venous Embolism NEC
 ;;^UTILITY(U,$J,358.3,17149,2)
 ;;=^338251
 ;;^UTILITY(U,$J,358.3,17150,0)
 ;;=425.11^^110^980^55
 ;;^UTILITY(U,$J,358.3,17150,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17150,1,4,0)
 ;;=4^425.11
 ;;^UTILITY(U,$J,358.3,17150,1,5,0)
 ;;=5^Hypertrophic Subaortic Stenosis
 ;;^UTILITY(U,$J,358.3,17150,2)
 ;;=^340520
 ;;^UTILITY(U,$J,358.3,17151,0)
 ;;=425.18^^110^980^61
 ;;^UTILITY(U,$J,358.3,17151,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17151,1,4,0)
 ;;=4^425.18
 ;;^UTILITY(U,$J,358.3,17151,1,5,0)
 ;;=5^Oth Hypertrophic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,17151,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,17152,0)
 ;;=V12.55^^110^980^50
 ;;^UTILITY(U,$J,358.3,17152,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17152,1,4,0)
 ;;=4^V12.55
 ;;^UTILITY(U,$J,358.3,17152,1,5,0)
 ;;=5^Hx of Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,17152,2)
 ;;=^340615
 ;;^UTILITY(U,$J,358.3,17153,0)
 ;;=414.4^^110^980^16
 ;;^UTILITY(U,$J,358.3,17153,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17153,1,4,0)
 ;;=4^414.4
 ;;^UTILITY(U,$J,358.3,17153,1,5,0)
 ;;=5^CAD d/t Calc Coronary Lesion
 ;;^UTILITY(U,$J,358.3,17153,2)
 ;;=^340518
 ;;^UTILITY(U,$J,358.3,17154,0)
 ;;=271.3^^110^981^17
 ;;^UTILITY(U,$J,358.3,17154,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17154,1,4,0)
 ;;=4^271.3
 ;;^UTILITY(U,$J,358.3,17154,1,5,0)
 ;;=5^Glucose Intolerance
 ;;^UTILITY(U,$J,358.3,17154,2)
 ;;=^64790
 ;;^UTILITY(U,$J,358.3,17155,0)
 ;;=611.1^^110^981^22
 ;;^UTILITY(U,$J,358.3,17155,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17155,1,4,0)
 ;;=4^611.1
 ;;^UTILITY(U,$J,358.3,17155,1,5,0)
 ;;=5^Gynecomastia
 ;;^UTILITY(U,$J,358.3,17155,2)
 ;;=^60454
 ;;^UTILITY(U,$J,358.3,17156,0)
 ;;=704.1^^110^981^23
